We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An FDA panel last week threw its support behind Abbott’s drug-eluting coronary stent Absorb, which, if approved, would become the first fully bioresorbable vascular scaffold in the U.S. Read More
The FDA has given the green light to Switzerland-based Sensimed AG for its Triggerfish, a contact lens embedded with a sensor that detects changes in an eye’s volume. Read More